List of Tables
Table 1. Global Autoimmune Disease Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Autoimmune Disease Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Autoimmune Disease Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Autoimmune Disease Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Autoimmune Disease Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Autoimmune Disease Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Autoimmune Disease Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Autoimmune Disease Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Autoimmune Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Autoimmune Disease Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Autoimmune Disease Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Autoimmune Disease Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Autoimmune Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Autoimmune Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Autoimmune Disease Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Autoimmune Disease Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Autoimmune Disease Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Autoimmune Disease Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Autoimmune Disease Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Autoimmune Disease Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Autoimmune Disease Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Autoimmune Disease Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Autoimmune Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Autoimmune Disease Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Autoimmune Disease Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Autoimmune Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Autoimmune Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Autoimmune Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Autoimmune Disease Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Autoimmune Disease Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Autoimmune Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Autoimmune Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Autoimmune Disease Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Autoimmune Disease Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Autoimmune Disease Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Autoimmune Disease Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Autoimmune Disease Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Autoimmune Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Autoimmune Disease Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Autoimmune Disease Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Autoimmune Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Autoimmune Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Autoimmune Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Autoimmune Disease Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Autoimmune Disease Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Autoimmune Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Autoimmune Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Autoimmune Disease Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Autoimmune Disease Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Autoimmune Disease Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Autoimmune Disease Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Autoimmune Disease Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Autoimmune Disease Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Autoimmune Disease Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Autoimmune Disease Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Autoimmune Disease Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Autoimmune Disease Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Autoimmune Disease Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Autoimmune Disease Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Autoimmune Disease Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Autoimmune Disease Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Autoimmune Disease Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Autoimmune Disease Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Autoimmune Disease Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Autoimmune Disease Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Autoimmune Disease Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Autoimmune Disease Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Qyuns Therapeutics Company Information
Table 71. Qyuns Therapeutics Description and Business Overview
Table 72. Qyuns Therapeutics Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Qyuns Therapeutics Autoimmune Disease Drugs Product
Table 74. Qyuns Therapeutics Recent Developments/Updates
Table 75. Bio-Thera Solutions Company Information
Table 76. Bio-Thera Solutions Description and Business Overview
Table 77. Bio-Thera Solutions Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bio-Thera Solutions Autoimmune Disease Drugs Product
Table 79. Bio-Thera Solutions Recent Developments/Updates
Table 80. Hengrui Pharmaceuticals Company Information
Table 81. Hengrui Pharmaceuticals Description and Business Overview
Table 82. Hengrui Pharmaceuticals Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Hengrui Pharmaceuticals Autoimmune Disease Drugs Product
Table 84. Hengrui Pharmaceuticals Recent Developments/Updates
Table 85. Hisun Pharmaceutical Company Information
Table 86. Hisun Pharmaceutical Description and Business Overview
Table 87. Hisun Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Hisun Pharmaceutical Autoimmune Disease Drugs Product
Table 89. Hisun Pharmaceutical Recent Developments/Updates
Table 90. Sunshine Guojian Pharmaceutical Company Information
Table 91. Sunshine Guojian Pharmaceutical Description and Business Overview
Table 92. Sunshine Guojian Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sunshine Guojian Pharmaceutical Autoimmune Disease Drugs Product
Table 94. Sunshine Guojian Pharmaceutical Recent Developments/Updates
Table 95. Chia Tai Tianqing Pharmaceutical Company Information
Table 96. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 97. Chia Tai Tianqing Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Chia Tai Tianqing Pharmaceutical Autoimmune Disease Drugs Product
Table 99. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 100. Chongqing Genrix Biopharmaceutical Company Information
Table 101. Chongqing Genrix Biopharmaceutical Description and Business Overview
Table 102. Chongqing Genrix Biopharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Chongqing Genrix Biopharmaceutical Autoimmune Disease Drugs Product
Table 104. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
Table 105. Keymed Biosciences Company Information
Table 106. Keymed Biosciences Description and Business Overview
Table 107. Keymed Biosciences Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Keymed Biosciences Autoimmune Disease Drugs Product
Table 109. Keymed Biosciences Recent Developments/Updates
Table 110. Junshi Biosciences Company Information
Table 111. Junshi Biosciences Description and Business Overview
Table 112. Junshi Biosciences Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Junshi Biosciences Autoimmune Disease Drugs Product
Table 114. Junshi Biosciences Recent Developments/Updates
Table 115. Akeso Company Information
Table 116. Akeso Description and Business Overview
Table 117. Akeso Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Akeso Autoimmune Disease Drugs Product
Table 119. Akeso Recent Developments/Updates
Table 120. AbbVie Company Information
Table 121. AbbVie Description and Business Overview
Table 122. AbbVie Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. AbbVie Autoimmune Disease Drugs Product
Table 124. AbbVie Recent Developments/Updates
Table 125. AstraZeneca Company Information
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. AstraZeneca Autoimmune Disease Drugs Product
Table 129. AstraZeneca Recent Developments/Updates
Table 130. Biogen Company Information
Table 131. Biogen Description and Business Overview
Table 132. Biogen Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Biogen Autoimmune Disease Drugs Product
Table 134. Biogen Recent Developments/Updates
Table 135. Bristol Myers Squibb Company Information
Table 136. Bristol Myers Squibb Description and Business Overview
Table 137. Bristol Myers Squibb Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bristol Myers Squibb Autoimmune Disease Drugs Product
Table 139. Bristol Myers Squibb Recent Developments/Updates
Table 140. Eli Lilly Company Information
Table 141. Eli Lilly Description and Business Overview
Table 142. Eli Lilly Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Eli Lilly Autoimmune Disease Drugs Product
Table 144. Eli Lilly Recent Developments/Updates
Table 145. GlaxoSmithKline Company Information
Table 146. GlaxoSmithKline Description and Business Overview
Table 147. GlaxoSmithKline Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. GlaxoSmithKline Autoimmune Disease Drugs Product
Table 149. GlaxoSmithKline Recent Developments/Updates
Table 150. Johnson & Johnson Company Information
Table 151. Johnson & Johnson Description and Business Overview
Table 152. Johnson & Johnson Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Johnson & Johnson Autoimmune Disease Drugs Product
Table 154. Johnson & Johnson Recent Developments/Updates
Table 155. Merck Company Information
Table 156. Merck Description and Business Overview
Table 157. Merck Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Merck Autoimmune Disease Drugs Product
Table 159. Merck Recent Developments/Updates
Table 160. Novartis AG Company Information
Table 161. Novartis AG Description and Business Overview
Table 162. Novartis AG Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Novartis AG Autoimmune Disease Drugs Product
Table 164. Novartis AG Recent Developments/Updates
Table 165. Pfizer Company Information
Table 166. Pfizer Description and Business Overview
Table 167. Pfizer Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Pfizer Autoimmune Disease Drugs Product
Table 169. Pfizer Recent Developments/Updates
Table 170. Roche Holding Company Information
Table 171. Roche Holding Description and Business Overview
Table 172. Roche Holding Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Roche Holding Autoimmune Disease Drugs Product
Table 174. Roche Holding Recent Developments/Updates
Table 175. Sanofi S.A. Company Information
Table 176. Sanofi S.A. Description and Business Overview
Table 177. Sanofi S.A. Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Sanofi S.A. Autoimmune Disease Drugs Product
Table 179. Sanofi S.A. Recent Developments/Updates
Table 180. Takeda Pharmaceutical Company Information
Table 181. Takeda Pharmaceutical Description and Business Overview
Table 182. Takeda Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Takeda Pharmaceutical Autoimmune Disease Drugs Product
Table 184. Takeda Pharmaceutical Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Autoimmune Disease Drugs Distributors List
Table 188. Autoimmune Disease Drugs Customers List
Table 189. Autoimmune Disease Drugs Market Trends
Table 190. Autoimmune Disease Drugs Market Drivers
Table 191. Autoimmune Disease Drugs Market Challenges
Table 192. Autoimmune Disease Drugs Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
Table 196. Authors List of This Report
List of Figures
Figure 1. Product Picture of Autoimmune Disease Drugs
Figure 2. Global Autoimmune Disease Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autoimmune Disease Drugs Market Share by Type: 2024 & 2031
Figure 4. Biopharma Product Picture
Figure 5. Small Molecule Drug Product Picture
Figure 6. Global Autoimmune Disease Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Autoimmune Disease Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Autoimmune Disease Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Autoimmune Disease Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Autoimmune Disease Drugs Sales (2020-2031) & (K Units)
Figure 14. Global Autoimmune Disease Drugs Average Price (US$/Unit) & (2020-2031)
Figure 15. Autoimmune Disease Drugs Report Years Considered
Figure 16. Autoimmune Disease Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Autoimmune Disease Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Autoimmune Disease Drugs Players: Market Share by Revenue in Autoimmune Disease Drugs in 2024
Figure 19. Autoimmune Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Autoimmune Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Autoimmune Disease Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Autoimmune Disease Drugs Revenue Market Share by Country (2020-2031)
Figure 23. United States Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Autoimmune Disease Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Autoimmune Disease Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Autoimmune Disease Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Autoimmune Disease Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Autoimmune Disease Drugs Sales Market Share by Country (2020-2031)
Figure 42. Latin America Autoimmune Disease Drugs Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Autoimmune Disease Drugs Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Autoimmune Disease Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Autoimmune Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Autoimmune Disease Drugs by Type (2020-2031)
Figure 53. Global Revenue Market Share of Autoimmune Disease Drugs by Type (2020-2031)
Figure 54. Global Autoimmune Disease Drugs Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Autoimmune Disease Drugs by Application (2020-2031)
Figure 56. Global Revenue Market Share of Autoimmune Disease Drugs by Application (2020-2031)
Figure 57. Global Autoimmune Disease Drugs Price (US$/Unit) by Application (2020-2031)
Figure 58. Autoimmune Disease Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
